Juanjuan Hao1, Xin Zhang2, Keyu Jiang2, Min Wu3. 1. Shanghai Jiao Tong University School of Medicine, 227 Chongqing Road, Shanghai, 200025, People's Republic of China. 2. Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, People's Republic of China. 3. Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, People's Republic of China. xinhuayiyuan123@126.com.
Abstract
OBJECTIVE: Neuron-specific enolase (NSE) has been suggested for demonstrating brain metabolism in neuropsychiatric disorders. This study assessed serum NSE levels in patients with tic disorders (TD). METHODS: In this retrospective case-control study, we investigated whether NSE levels were increased in TD patients. Then, the influencing factors and correlations between NSE levels and clinical features were analyzed. Finally, we tested its diagnostic value for identifying tic severity. RESULTS: NSE levels were increased in TD patients, although no statistically significant difference was present between transient TD, chronic TD, and Tourette syndrome. Factors influencing NSE levels assessed by multiple linear regression were the Yale Global Tic Severity Scale (YGTSS) global severity scores and gender. There were significant correlations between NSE levels and tic severity. The optimal cut-off value to distinguish mild tics from moderate-severe tics estimated by receiver operating characteristics curve was 24.95 ng/ml (AUC = 0.683). CONCLUSION: Our findings suggested that NSE may be a significant biomarker in TD but should be confirmed in further investigation.
OBJECTIVE:Neuron-specific enolase (NSE) has been suggested for demonstrating brain metabolism in neuropsychiatric disorders. This study assessed serum NSE levels in patients with tic disorders (TD). METHODS: In this retrospective case-control study, we investigated whether NSE levels were increased in TDpatients. Then, the influencing factors and correlations between NSE levels and clinical features were analyzed. Finally, we tested its diagnostic value for identifying tic severity. RESULTS:NSE levels were increased in TDpatients, although no statistically significant difference was present between transient TD, chronic TD, and Tourette syndrome. Factors influencing NSE levels assessed by multiple linear regression were the Yale Global Tic Severity Scale (YGTSS) global severity scores and gender. There were significant correlations between NSE levels and tic severity. The optimal cut-off value to distinguish mild tics from moderate-severe tics estimated by receiver operating characteristics curve was 24.95 ng/ml (AUC = 0.683). CONCLUSION: Our findings suggested that NSE may be a significant biomarker in TD but should be confirmed in further investigation.
Authors: João Vicente Busnello; Renata Leke; Jean Pierre Oses; Gustavo Feier; Ricardos Bruch; João Quevedo; Flávio Kapczinski; Diogo O Souza; Luis Valmor Cruz Portela Journal: Life Sci Date: 2006-01-18 Impact factor: 5.037
Authors: Michael H Bloch; Bradley S Peterson; Lawrence Scahill; Jessica Otka; Lily Katsovich; Heping Zhang; James F Leckman Journal: Arch Pediatr Adolesc Med Date: 2006-01
Authors: T Cronberg; M Rundgren; E Westhall; E Englund; R Siemund; I Rosén; H Widner; H Friberg Journal: Neurology Date: 2011-07-20 Impact factor: 9.910
Authors: Rodrigo Machado-Vieira; Ana Cristina Andreazza; Carlos Ivan Viale; Vanessa Zanatto; Victor Cereser; Rafael da Silva Vargas; Flávio Kapczinski; Luiz V Portela; Diogo O Souza; Mirian Salvador; Valentim Gentil Journal: Neurosci Lett Date: 2007-05-22 Impact factor: 3.046